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LETTERS TO THE EDITOR
Batista’s Operation: What Have We Learned?
The recent editorial comment by Dr. Ratcliffe (1) on two articles
(2,3) concerning partial left ventriculectomy (PLV) raises some
issues that we would like to clarify. In his comment Dr. Ratcliffe
questions the accuracy of the conductance catheter method based
upon a comparison between our measurements obtained by ther-
modilution and conductance catheter. The illustration presented
(Fig. 1 of his comment) appears to demonstrate poor agreement
between the two methods. Unfortunately, this is due to a misin-
terpretation of the data presented in Table 2 in our article (3).
Figure 1 in Dr. Ratcliffe’s comment shows a comparison between
stroke volume (SV) measured by thermodilution and by conduc-
tance catheter, the latter using the difference between left ventric-
ular (LV) end-diastolic volume (EDV) and end-systolic volume
(ESV). However, whereas thermodilution measures effective for-
ward flow, the difference between EDV and ESV also includes
both mitral and aortic regurgitant flows. Therefore, the difference
between the measurements by the two methods, as plotted on the
y-axis of Figure 1, in fact represents the sum of aortic and mitral
regurgitant stroke volumes. Thus, the finding that this difference is
substantial (mean difference 18 ml) merely reflects the presence of
substantial mitral and aortic regurgitation in this patient group.
In retrospect we performed the same analysis as Dr. Ratcliffe,
and we subsequently separately analyzed data before and after
PLV. Before PLV, mean regurgitant SV was 27 6 19 ml, whereas
post-PLV it was reduced to 12 6 10 ml, consistent with the aortic
valve surgery performed in one patient and mitral valve surgery
performed in seven patients. Furthermore, the conductance vol-
umes as presented in Table 2 in our article (3) are, in fact,
calibrated by matching thermodilution-derived SV with effective
conductance SV (p. 2106 of our article). The latter is obtained as
the difference between conductance volumes at the times of
dP/dtMIN and dP/dtMAX, which largely eliminates the contribu-
tion of regurgitant flows. As mentioned in our study, this calibra-
tion on the basis of thermodilution was performed in each patient
at each condition. Therefore, a comparison between thermodilu-
tion and conductance-derived SV, as attempted in the editorial
comment, is not meaningful.
A striking observation of the present and other PLV studies is
the unchanged SV after the procedure in these patients. One of our
main findings, unfortunately not discussed in the editorial com-
ment, was the improvement in mechanical LV synchrony. Me-
chanical nonuniformity as demonstrated in these patients is an
important factor in cardiac dysfunction in heart failure patients.
Our results indicate, as demonstrated by the highly significant
positive correlation between cardiac index and LV synchrony
index, that PLV produces its beneficial effects partly by improving
mechanical synchrony. The increase in LV synchrony immediately
after PLV may lead to an improved mechanical efficiency of
ventricular ejection, compensating an expected decrease in SV.
In our view the occurrence of the marked change in LV
segmental asynchrony precludes realistic estimation of the effects
of PLV on the Starling relationship (SV vs. sarcomere length),
because mean sarcomere lengths before and after PLV are un-
known and cannot simply be derived from LV end-diastolic
pressure (EDP) or LV EDV due to the change in LV segmental
asynchrony. Moreover, the excision of LV mass and concomitant
change of LV intracavitary volume also preclude estimation of
sarcomere length change from both EDV and EDP.
Finally, it would be interesting to implement LV segmental
volume asynchrony in models such as used by Dickstein et al. (4)
and by Ratcliffe et al. (5). In general, we agree that numerical
models may provide data that are difficult or impossible to obtain
in in vivo studies. However, studies such as described by Starling
et al. (2) and by us (3) will always be required initially to feed the
numerical models with input data and ultimately to check whether
the results produced by these models are meaningful and consistent
with data obtained in the intact heart.
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A Randomized Trial of
Multivessel Stent Versus Coronary Bypass
In a recent Journal article, Rodriguez et al. (1) reported that the
rates of death and myocardial infarction during long-term
follow-up were lower in patients undergoing percutaneous trans-
luminal coronary revascularization (PTCR) than in patients un-
dergoing coronary artery bypass graft (CABG) surgery. This
conclusion requires careful scrutiny owing to possible under-
reporting of major events.
The study was designed with a composite primary end point
that included death, myocardial infarction, cerebrovascular acci-
dent and myocardial re-revascularization. Presumably, once a
patient experienced a primary end point event, that patient would
be withdrawn from further analysis. A patient who underwent a
second revascularization procedure and subsequently died would
not be reported as a death, for example. In the Rodriguez et al.
study, patients randomized to PTCR were more likely to have a
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